Article
Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene.
European journal of cancer (Oxford, England : 1990) - 1 May 2004
Beilby J, Ingram D, Hähnel R, Rossi E
Abstract excerpt
Breast cancer risk may be associated with folate status or the C677T genotype of the methylenetetrahydrofolate reductase (MTHFR) gene. We compared serum folate concentrations and C677T genotype in 141 breast cancer patients and 109 age-matched controls. Serum folate was significantly lower in cases compared to controls (geometric means, 5.7 versus 6.6 microg/l; P=0.005). Breast cancer risk was not associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
